Gloria M Reyes

Recommended Articles

• Facts Every Celiac Patient Should Know

  When someone is diagnosed with celiac disease they have to make significant lifestyle changes to ensure that they can properly manage their disorder. To make those changes, it’s critical that the patient and their family members have a proper understanding of celiac disease and how it affects a...

• Revealing a Terminal Ovarian Cancer: A Personal Story

  A terminal cancer diagnosis is an extremely difficult thing to process, and the hardship is only amplified when sharing the news with someone who loves you. There is a stress surrounding how to break the news, and a worry for how they will cope with it.This is how Linda Tierney decided to tell her...

• Prostate Cancer: What are the Different Medical Procedures for this Condition?

  Prostate cancer is one of the most common cancers among men. There are a number of ways to treat prostate cancer. Every method involves a process of decision making, support from friends and family, and understanding side effects that result from the treatments and dealing with them.Men with...

• Airforce Veteran Finds Joy in Being a Nurse

  Jonathan Haag turned his life around after a life-changing injury and used his experience to became a nurse. Jonathan went through a condition that still affects him today, but he is much stronger now and uses his experiences to heal those around him. Jonathan has an incredible story of hope,...

• What is Turf Toe?

  Turf toe refers to the painful injury to the big toe, and is very common in athletes in field sports, such as  football, baseball, and soccer. This injury is common in activities that occur on grass or artificial turf. It can affect any other person who is involved in activities that extend the toe...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...